Cohen & Steers, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Joseph Martin Harvey
- Full Time Employees
- 424
- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 1166 Avenue of the Americas New York City NY United States of America 10017
- IPO Date
- Aug 16, 2004
- CIK
- 0001284812
- Website
- cohenandsteers.com
- Similar Companies
- Business
- Cohen & Steers, Inc. (NYSE: CNS) is an asset management firm specializing in real assets and alternative investments. The company offers a diverse range of products including closed-end funds, exchange-traded funds (ETFs), mutual funds, and separately managed accounts focused on real estate securities, infrastructure equities, preferred securities, utilities, and commodities; it also provides sub-advisory services and model portfolios to institutional and retail investors worldwide. Cohen & Steers operates primarily in the United States, Europe, and Asia, serving institutional clients such as pension funds, endowments, and sovereign wealth funds, as well as individual investors through intermediary channels. Founded in 1986 and headquartered in New York City, the firm manages approximately $85 billion in assets under management as of late 2025, with key subsidiaries including Cohen & Steers Capital Management, Inc.. In recent developments, Cohen & Steers launched several new ETFs in 2024 and 2025, including the Cohen & Steers Real Estate Securities and Utilities ETF and expanded its infrastructure-focused offerings to capitalize on global energy transition trends; the company also completed a strategic partnership with a major European pension fund in mid-2025 to enhance distribution of its alternative strategies across the region. Additionally, Cohen & Steers raised $500 million through a new closed-end fund issuance in Q3 2025 targeting U.S. infrastructure debt, marking its largest such offering in two years, and announced the acquisition of a boutique preferred securities manager to bolster its fixed-income alternatives platform. These moves reflect the firm's ongoing expansion into high-growth segments amid rising demand for real asset diversification.
Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
Cohen & Steers Appoints Erik Schneberger as Chief Marketing Officer
Cohen & Steers Q2: Rally Reflects Improving Real Estate Flows (Downgrade)
Cohen & Steers, Inc. (CNS) Q2 2026 Earnings Call Transcript
Cohen & Steers Q2 Earnings Call Highlights
COHEN & STEERS REPORTS RESULTS FOR SECOND QUARTER 2026
Cohen & Steers Quality Income Realty Fund, Inc. Announces Preliminary Results of Transferable Rights Offering
Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide® in Leptomeningeal Metastases Monitoring
New Healthcare Claims Study Published in CNS Spectrums Finds High Rates of Treatment Switching, Discontinuation, and Prolonged Gaps in Care Among Patients with Generalized Anxiety Disorder (GAD)
Cohen & Steers: Diversification From Mag 7
The REIT Strategy I Would Use To Retire Today
Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for June 2026
Cohen & Steers, Inc. to Release Second Quarter 2026 Results on July 16, 2026
Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)
Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)
Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)
Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a)
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
Monthly Income Funds From Cohen & Steers (June Update)